Skip to main content
. 2018 Jan 2;9(6):7066–7074. doi: 10.18632/oncotarget.23829

Table 2. Distribution of HLA-DP/DQ and STAT4 alleles in IgA nephropathy patients and healthy controls.

Genes SNPs Alleles Controls (%) IgAN (%) Crude OR (95% CI) P Adjusted OR (95% CI) p*
HLA-DP rs3077 Allele G 658 (67.1) 157 (56.1) 1.00 (ref.) 1.00 (ref.)
Allele A 322 (32.9) 123 (43.9) 1.60 (1.22–2.09) 0.001 1.69 (1.28–2.24) 2.2E-04
HWE p = 0.93 p =1.9E-15
HLA-DP rs9277535 Allele G 610 (62.2) 128 (45.7) 1.00 (ref.) 1.00 (ref.)
Allele A 370 (37.8) 152 (54.3) 1.96 (1.49–2.56) 1.0E-06 1.99 (1.52–2.63) 1.0E-06
HWE p = 0.99 p = 0.01
HLA-DQ rs7453920 Allele G 855 (87.2) 251 (89.6) 1.00 (ref.) 1.00 (ref.)
Allele A 125 (12.8) 29 (10.4) 0.79 (0.51–1.21) 0.28 0.70 (0.45–1.08) 0.11
HWE p = 0.26 p = 0.39
STAT4 rs7574865 Allele G 652 (66.5) 160 (57.1) 1.00 (ref.) 1.00 (ref.)
Allele T 328 (33.5) 120 (42.9) 1.49 (1.14–1.96) 0.004 1.60 (1.21–2.12) 0.001
HWE p =0.82 p = 1.9E-08

OR: odds ratio; CI: confidence interval; HWE: Hardy-Weinberg equilibrium.

*Logistic regression controlling for age and sex.

Bold values are statistically significant (p < 0.05).